Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENV-294 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
NCT07643766Phase 2Recruiting
- Sponsor
- Enveda Biosciences
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of ENV-294 in atopic dermatitis (AD), sponsored by Enveda Biosciences. Started Jun 2026; status: recruiting.
02
Drugs
ENV-294
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07643766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07643766.